Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott D Nelson

Showing results (121-130 of 196) with videos related to

Pageof 20
Sort By:
Journal of Cellular Biochemistry|January 21, 2017
Tumor-Targeting Salmonella typhimurium A1-R Sensitizes Melanoma With a BRAF-V600E Mutation to Vemurafenib in a Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse ModelKei Kawaguchi, Kentaro Igarashi, Takashi Murakami, et al.
Cell Cycle (Georgetown, Tex.)|November 11, 2016
Patient-derived orthotopic xenograft (PDOX) mouse model of adult rhabdomyosarcoma invades and recurs after resection in contrast to the subcutaneous ectopic modelKentaro Igarashi, Kei Kawaguchi, Tasuku Kiyuna, et al.
American Journal of Clinical Oncology|March 27, 2019
Pathologic Response to Neoadjuvant Therapy is Associated With Improved Long-term Survival in High-risk Primary Localized Malignant Peripheral Nerve Sheath TumorsElizabeth Shurell-Linehan, Benjamin J DiPardo, Irmina A Elliott, et al.
Anticancer Research|July 26, 2017
Efficacy In Vitro of Caffeine and Valproic Acid on Patient-Derived Undifferentiated Pleomorphic Sarcoma and Rhabdomyosarcoma Cell LinesKentaro Igarashi, Kei Kawaguchi, Tasuku Kiyuna, et al.
Oncotarget|November 5, 2017
Temozolomide combined with irinotecan caused regression in an adult pleomorphic rhabdomyosarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse modelKentaro Igarashi, Kei Kawaguchi, Tasuku Kiyuna, et al.
Oncotarget|November 12, 2016
Tumor-targeting Salmonella typhimurium A1-R combined with temozolomide regresses malignant melanoma with a BRAF-V600E mutation in a patient-derived orthotopic xenograft (PDOX) modelKei Kawaguchi, Kentaro Igarashi, Takashi Murakami, et al.
Nature Communications|January 11, 2022
Integrating gene expression and clinical data to identify drug repurposing candidates for hyperlipidemia and hypertensionPatrick Wu, QiPing Feng, Vern Eric Kerchberger, et al.
American Journal of Clinical Oncology|August 23, 2019
Oncologic Accuracy of Image-guided Percutaneous Core-Needle Biopsy of Peripheral Nerve Sheath Tumors at a High-volume Sarcoma CenterDanielle S Graham, Tara A Russell, Mark A Eckardt, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 12, 2020
ASHP Statement on the Use of Artificial Intelligence in PharmacyNick Schutz, Casey A Olsen, Andrew J McLaughlin, et al.
Cell Cycle (Georgetown, Tex.)|February 1, 2018
Individualized doxorubicin sensitivity testing of undifferentiated soft tissue sarcoma (USTS) in a patient-derived orthotopic xenograft (PDOX) model demonstrates large differences between patientsKei Kawaguchi, Kentaro Igarashi, Tasuku Kiyuna, et al.
Pageof 20

Showing results (121-130 of 196) with videos related to

Sort By:
Pageof 20
Journal of Cellular Biochemistry|January 21, 2017
Tumor-Targeting Salmonella typhimurium A1-R Sensitizes Melanoma With a BRAF-V600E Mutation to Vemurafenib in a Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse ModelKei Kawaguchi, Kentaro Igarashi, Takashi Murakami, et al.
Cell Cycle (Georgetown, Tex.)|November 11, 2016
Patient-derived orthotopic xenograft (PDOX) mouse model of adult rhabdomyosarcoma invades and recurs after resection in contrast to the subcutaneous ectopic modelKentaro Igarashi, Kei Kawaguchi, Tasuku Kiyuna, et al.
American Journal of Clinical Oncology|March 27, 2019
Pathologic Response to Neoadjuvant Therapy is Associated With Improved Long-term Survival in High-risk Primary Localized Malignant Peripheral Nerve Sheath TumorsElizabeth Shurell-Linehan, Benjamin J DiPardo, Irmina A Elliott, et al.
Anticancer Research|July 26, 2017
Efficacy In Vitro of Caffeine and Valproic Acid on Patient-Derived Undifferentiated Pleomorphic Sarcoma and Rhabdomyosarcoma Cell LinesKentaro Igarashi, Kei Kawaguchi, Tasuku Kiyuna, et al.
Oncotarget|November 5, 2017
Temozolomide combined with irinotecan caused regression in an adult pleomorphic rhabdomyosarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse modelKentaro Igarashi, Kei Kawaguchi, Tasuku Kiyuna, et al.
Oncotarget|November 12, 2016
Tumor-targeting Salmonella typhimurium A1-R combined with temozolomide regresses malignant melanoma with a BRAF-V600E mutation in a patient-derived orthotopic xenograft (PDOX) modelKei Kawaguchi, Kentaro Igarashi, Takashi Murakami, et al.
Nature Communications|January 11, 2022
Integrating gene expression and clinical data to identify drug repurposing candidates for hyperlipidemia and hypertensionPatrick Wu, QiPing Feng, Vern Eric Kerchberger, et al.
American Journal of Clinical Oncology|August 23, 2019
Oncologic Accuracy of Image-guided Percutaneous Core-Needle Biopsy of Peripheral Nerve Sheath Tumors at a High-volume Sarcoma CenterDanielle S Graham, Tara A Russell, Mark A Eckardt, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 12, 2020
ASHP Statement on the Use of Artificial Intelligence in PharmacyNick Schutz, Casey A Olsen, Andrew J McLaughlin, et al.
Cell Cycle (Georgetown, Tex.)|February 1, 2018
Individualized doxorubicin sensitivity testing of undifferentiated soft tissue sarcoma (USTS) in a patient-derived orthotopic xenograft (PDOX) model demonstrates large differences between patientsKei Kawaguchi, Kentaro Igarashi, Tasuku Kiyuna, et al.
Pageof 20